Effects of insulin and the glucagon-like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice
- PMID: 28330952
- PMCID: PMC5371560
- DOI: 10.14814/phy2.13187
Effects of insulin and the glucagon-like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice
Abstract
Diabetes mellitus (DM) is a worldwide disease that affects 9% of the adult world population and type 2 DM accounts for 90% of those. A common consequence of DM is kidney complications, which could lead to kidney failure VSports手机版. We studied the potential effects of treatment with insulin and the glucagon-like peptide 1 receptor (GLP-1R) agonist liraglutide on the diabetic kidney proteome through the use of the db/db mouse model system and mass spectrometry (MS). Multivariate analyses revealed distinct effects of insulin and liraglutide on the db/db kidney proteome, which was seen on the protein levels of, for example, pterin-4 α-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor-1α (PCBD1), neural precursor cell expressed developmentally down-regulated-8 (NEDD8), transcription elongation factor-B polypeptide-1 (ELOC) and hepcidin (HEPC). Furthermore, the separation of the insulin, liraglutide and vehicle db/db mouse groups in multivariate analyses was not mainly related to the albumin excretion rate (AER) or the level of glycated hemoglobin A1c (HbA1c%) in the mice. In summary, we show that insulin and liraglutide give rise to separate protein profiles in the db/db mouse kidney. .
Keywords: GLP‐1R agonist liraglutide; OPLS‐DA; insulin; kidney proteome V体育安卓版. .
© 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. V体育ios版.
"V体育官网" Figures
References
-
- Andersen, C. L. , Jensen J. L., and Ørntoft T. F.. 2004. Normalization of real‐time quantitative reverse transcription‐PCR data: a model‐based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64:5245–5250. doi:10.1158/0008‐5472.CAN‐04‐0496. - DOI - PubMed
-
- Andresen, C. A. , Smedegaard S., Sylvestersen K. B., Svensson C., Iglesias‐Gato D., Cazzamali G., et al. 2014. Protein interaction screening for the ankyrin repeats and suppressor of cytokine signaling (SOCS) box (ASB) family identify Asb11 as a novel endoplasmic reticulum resident ubiquitin ligase. J. Biol. Chem. 289:2043–2054. doi:10.1074/jbc.M113.534602. - DOI - PMC - PubMed
-
- Astrup, A. S. , Tarnow L., Pietraszek L., Schalkwijk C. G., Stehouwer C. D. A., Parving H.‐H., et al. 2008. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care 31:1170–1176. doi:10.2337/dc07‐1960. - DOI - PubMed
-
- Befroy, D. E. , Petersen K. F., Dufour S., Mason G. F., de Graaf R. A., Rothman D. L., et al. 2007. Impaired mitochondrial substrate oxidation in muscle of insulin‐resistant offspring of type 2 diabetic patients. Diabetes 56:1376–1381. doi:VSports在线直播 - 10.2337/db06‐0783. - DOI - PMC - PubMed
-
- den Besten, W. , Verma R., Kleiger G., Oania R. S., and Deshaies R. J.. 2012. NEDD8 links cullin‐RING ubiquitin ligase function to the p97 pathway. Nat. Struct. Mol. Biol. Nature Publishing Group, 19:511–516, S1. doi: 10.1038/nsmb.2269. - DOI - PMC - PubMed
MeSH terms
- "V体育平台登录" Actions
- "VSports app下载" Actions
- Actions (V体育ios版)
- Actions (V体育平台登录)
Substances (V体育ios版)
- V体育官网 - Actions
- Actions (VSports最新版本)
- V体育平台登录 - Actions
- V体育官网入口 - Actions
- "V体育安卓版" Actions
- "V体育ios版" Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical (VSports最新版本)
Molecular Biology Databases
V体育2025版 - Miscellaneous
